Today
-3.08%
5 Days
+3.35%
1 Month
-1.14%
6 Months
-3.34%
Year to Date
-16.71%
1 Year
-14.67%
• Tesla faced downward stock pressure after its third-quarter financial results. • Lowered capital expenditure forecasts raised investor concerns about slowing AI investments. • Technical indicators show a MACD buy signal and neutral RSI conditions.
• Tesla formed committees to evaluate a potential merger with SpaceX. • Third-quarter results and autonomous transport progress drove investor focus. • Technical indicators show a buy signal with extremely bullish sentiment.
• General Motors reported third-quarter results that surpassed Wall Street consensus estimates. • Investors reacted negatively because the profit guidance missed analyst expectations. • Technical indicators show mixed signals alongside a moderate level of media coverage.
• Tesla shares rose amid volatility ahead of third-quarter earnings. • Strong vehicle deliveries reaffirmed robust global underlying demand. • Strategic alignment across artificial intelligence energized investor sentiment.
• Rising capital expenditures and AI investments raised concerns about near-term profitability constraints. • Third-quarter vehicle deliveries declined year-over-year amid pricing pressures and softening Chinese demand. • Technical indicators show a neutral MACD and RSI, with Williams %R suggesting selling.
• Tesla reported third-quarter vehicle deliveries exceeding market consensus expectations significantly. • Institutional buying increased due to autonomous driving and energy storage growth. • Tesla shows an annual revenue of $94.83B and net profit of $3.79B.
Tesla (TSLA) Q3 2026 Earnings Call: FSD, Robotaxi and Optimus Ramp


| Shareholders | Proportion |
|---|---|
| Musk (Elon Reeve) | 11.00% |
| Vanguard Capital Management, LLC | 4.87% |
| BlackRock Institutional Trust Company, N.A. | 3.59% |
| State Street Investment Management (US) | 3.06% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 26.01% |
| Investment Advisor/Hedge Fund | 12.14% |
| Individual Investor | 11.09% |
| Research Firm | 1.97% |
Related Instruments